FDA May Need To Reduce Timeframe For Inspecting Flu Vaccine Facilities, Rep. Davis Says
This article was originally published in The Pink Sheet Daily
Executive Summary
House Government Reform Committee Chairman Tom Davis (R-Va.) indicated interest in revising FDA's procedures regarding inspection of flu vaccine manufacturing facilities in light of the current supply shortage